Cationic antimicrobial peptides: potential templates for anticancer agents

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Cancer remains a leading global cause of mortality, necessitating novel therapeutic strategies.
• Antimicrobial peptides (AMPs) exhibit potential anticancer activity, with cationic AMPs (CAMPs) showing particular promise.
• CAMPs selectively target cancer cells via electrostatic interactions with their negatively charged membranes.

Purpose of the Study:

• To review the anticancer properties of specific cationic antimicrobial peptides (CAMPs).
• To explore the advantages of CAMPs as potential cancer therapeutics.
• To briefly discuss bioinformatics tools used in the selection of anticancer peptides (ACPs).

Main Methods:

• Literature review of studies on CAMPs with anticancer activity.
• Focus on specific CAMP examples: KLA, bovine lactoferricin derivatives, and LTX-315.
• Overview of bioinformatics approaches for identifying anticancer peptides from AMP databases.

Main Results:

• CAMPs demonstrate high specificity for cancer cells with minimal toxicity to normal cells.
• Advantages include reduced resistance development, stability, and ease of modification.
• Selected CAMPs like KLA and LTX-315 show significant anticancer potential.

Conclusions:

• CAMPs represent a promising class of novel anticancer agents.
• Their unique mechanism of action and favorable characteristics warrant further investigation.
• Bioinformatics tools can aid in the discovery and development pipeline for CAMP-based cancer therapies.